Propionyl-L-carnitine for intermittent claudication-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Propionyl-L-carnitine for intermittent claudication

Published:2021-12-26 Issue:12 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kamoen Victor¹,Vander Stichele Robert²,Campens Laurence³⁴,De Bacquer Dirk⁵,Van Bortel Luc²,de Backer Tine LM²⁴

Affiliation:

1. Faculty of Medicine and Health Sciences; Ghent University; Ghent Belgium

2. Heymans Institute of Pharmacology; Ghent University; Ghent Belgium

3. Center for Medical Genetics; Ghent University Hospital; Ghent Belgium

4. Cardiovascular Center; Ghent University Hospital; Ghent Belgium

5. Department of Public Health; Ghent University; Ghent Belgium

Publisher

Wiley

Subject

Pharmacology (medical)

Reference58 articles.

1. Levo-propionyl-carnitine improves the effectiveness of supervised physical training on the absolute claudication distance in patients with intermittent claudication;Andreozzi;Angiology,2008

2. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study;Brevetti;European Heart Journal,1992

3. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study;Brevetti;Journal of American College of Cardiology,1995

4. Effect of propionyl-L-carnitine on quality of life in intermittent claudication;Brevetti;American Journal of Cardiology,1997

5. European multicenter study on propionyl-l-carnitine in intermittent claudication;Brevetti;Journal of American College of Cardiology,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selected Plant-Derived Polyphenols as Potential Therapeutic Agents for Peripheral Artery Disease: Molecular Mechanisms, Efficacy and Safety;Molecules;2022-10-21

2. How does propionyl-L-carnitine compare with placebo for adults with intermittent claudication?;Cochrane Clinical Answers;2022-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3